Bupropion sustained release and smoking cessation

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL.4, 1998, Pages 66-72

  Goldstein, Michael G ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANOREXIGENIC AGENT; BUSPIRONE; CARBON MONOXIDE; CATECHOLAMINE; CLONIDINE; COTININE; DOPAMINE; ENDORPHIN; HYPOPHYSIS HORMONE; MECAMYLAMINE; NEUROTRANSMITTER; NICOTINE; PSYCHOTROPIC AGENT; SEROTONIN; VASOPRESSIN;

AFFECTIVE NEUROSIS; CIGARETTE SMOKING; CLINICAL TRIAL; DEPENDENT PERSONALITY DISORDER; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; EXERCISE; HUMAN; HYPNOSIS; INHALATIONAL DRUG ADMINISTRATION; INSOMNIA; INTRANASAL DRUG ADMINISTRATION; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOSOCIAL CARE; REVIEW; SMOKING CESSATION; SOCIAL SUPPORT; SUSTAINED RELEASE PREPARATION; TOBACCO; TRAINING; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADMINISTRATION, CUTANEOUS; ADULT; AMBULATORY CARE; BUPROPION; CLINICAL TRIALS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MOOD DISORDERS; NICOTINE; PRACTICE GUIDELINES; SELF MEDICATION; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 0031940879     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. US Department of Health and Human Services, Surgeon General. The Health Consequences of Smoking: Nicotine Addiction. Rockville, Md: Public Health Service, Centers for Disease Control; 1988. US Dept Health and Human Services publication (CDC) 88-8406
2. McGinnis J, Foege W. Actual causes of death in the United States. JAMA 1993;270:2207-2212
3. Peto P, Lopez A, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull 1996;52:12-21
4. Centers for Disease Control. Cigarette smoking among adults: United States, 1994. MMWR Morb Mortal Wkly Rep 1996;45:588-590
5. Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993;150:546-553
6. Hughes J, Hatsukami D, Mitchell J, et al. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986;143:993-997
7. Velicer WF, Fava JL, Prochaska JO, et al. Distribution of smokers by stage in three representative samples. Prev Med 1995;24:401-411
8. Lichtenstein E, Glasgow R. Smoking cessation: what have we learned over the past decade? J Consult Clin Psychol 1992;60:518-527
9. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Nicotine Dependence. Am J Psychiatry 1996;153(10, suppl):1-31
10. Fiore M, Bailey W, Cohen S, et al. Smoking Cessation: Clinical Practice Guideline No. 18: Rockville, Md: Agency for Health Care Policy and Research, Public Health Service; 1996. US Dept Health and Human Services
11. Henningfield J, Cohen C, Pickworth W. Psychopharmacology of nicotine. In: Orleans CT, Slade J, eds. Nicotine Addiction: Principles and Management. New York, NY: Oxford University Press; 1993:24-45
12. Pomerleau O, Pomerleau C. Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 1984;8:503-513
13. Clarke P. Nicotine dependence: mechanisms and therapeutic strategies. Biochem Soc Symp 1994;59:83-85
14. Pontieri F, Tanda G, Orzi F, et al. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996;382:255-257
15. Solomon L, Flynn B. Women who smoke. In: Orleans CT, Slade J, eds. Nicotine Addiction: Principles and Management. New York, NY: Oxford University Press; 1993:339-349
16. Breslau N, Kilbey M, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 1991;48:1069-1074
17. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992;149:464-469
18. Hall SM, Munoz R, Reus V. Smoking cessation, depression and dysphoria. NIDA Res Monogr 1991;105:312-313
19. Covey L, Glassman A, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990;31:350-354
20. Bock BC, Goldstein MG, Marcus BH. Depression following smoking cessation in women. J Subst Abuse 1996;8:137-144
21. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997;154:263-265
22. Stage KB, Glassman AH, Covey LS. Depression after smoking cessation: case reports. J Clin Psychiatry 1996;57:467-469
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
24. Hughes J, Hatsukami D. The nicotine withdrawal syndrome: a brief review end update. International Journal of Smoking Cessation 1992;1:21-26
25. Hughes J, Higgins S, Hatsukami D. Effects of abstinence from tobacco: a critical review. In: Kozlowski L, Annis H, Cappell H, et al., eds. Recent Advances in Alcohol and Drug Problems, vol 10. New York, NY: Plenum; 1990:317-398
26. Tang J, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-26
27. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994;271:1940-1947
28. Cepeda-Benito A. A meta-analytic review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 1993; 61:822-830
29. Lam W, Sze PC, Sacks HS, et al. Meta-analysis of randomized controlled trials of nicotine chewing-gum. Lancet 1987;2:27-30
30. Po A. Transdermal nicotine in smoking cessation: a meta-analysis. Eur J Clin Pharmacol 1993;24:519-528
31. Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-142
32. Goldstein MG, Niaura R, Follick MJ, et al. Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation. Am J Psychiatry 1989;146:56-60
33. Tønnesen P, Nørregaard J, Simonsen K, et al. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-315
34. Schneider N, Olmstead R, Mody F, et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995;90:1671-1682
35. Ascher JA, Cole JO, Colin J-N, et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401
36. Ferry L, Burchette R. Evaluation of bupropion versus placebo for treatment of nicotine dependence. In: New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association; May 26, 1994; Philadelphia, Pa. Abstract NR554:199-200
37. Hurt R, Glover E, Sachs D, et al. Bupropion for smoking cessation: a double-blind, placebo-controlled dose response trial. J Addict Dis 1996;15: 137
38. Niaura R, Goldstein M, DePue J, et al. Fluoxetine, symptoms of depression, and smoking cessation. Annals of Behavioral Medicine 1995;17 (suppl):S061
39. Dalack GW, Glassman AH, Rivelli S, et al. Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry 1995;152: 398-403
40. Rudorfer MV, Manji HK, Potter WZ. Comparative tolerability profiles of the newer versus older antidepressants. Drug Saf 1994;10:18-46